1. Home
  2. ROIV vs WTFC Comparison

ROIV vs WTFC Comparison

Compare ROIV & WTFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • WTFC
  • Stock Information
  • Founded
  • ROIV 2014
  • WTFC 1991
  • Country
  • ROIV United Kingdom
  • WTFC United States
  • Employees
  • ROIV N/A
  • WTFC N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • WTFC Major Banks
  • Sector
  • ROIV Health Care
  • WTFC Finance
  • Exchange
  • ROIV Nasdaq
  • WTFC Nasdaq
  • Market Cap
  • ROIV 8.4B
  • WTFC 7.8B
  • IPO Year
  • ROIV N/A
  • WTFC N/A
  • Fundamental
  • Price
  • ROIV $10.76
  • WTFC $122.29
  • Analyst Decision
  • ROIV Buy
  • WTFC Strong Buy
  • Analyst Count
  • ROIV 4
  • WTFC 15
  • Target Price
  • ROIV $17.50
  • WTFC $131.67
  • AVG Volume (30 Days)
  • ROIV 5.8M
  • WTFC 421.8K
  • Earning Date
  • ROIV 05-29-2025
  • WTFC 04-21-2025
  • Dividend Yield
  • ROIV N/A
  • WTFC 1.64%
  • EPS Growth
  • ROIV N/A
  • WTFC 4.71
  • EPS
  • ROIV N/A
  • WTFC 10.13
  • Revenue
  • ROIV $122,585,000.00
  • WTFC $2,383,650,000.00
  • Revenue This Year
  • ROIV N/A
  • WTFC $15.72
  • Revenue Next Year
  • ROIV N/A
  • WTFC $5.34
  • P/E Ratio
  • ROIV N/A
  • WTFC $12.07
  • Revenue Growth
  • ROIV 140.04
  • WTFC 8.51
  • 52 Week Low
  • ROIV $8.73
  • WTFC $89.10
  • 52 Week High
  • ROIV $13.06
  • WTFC $142.04
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 49.48
  • WTFC 67.42
  • Support Level
  • ROIV $10.58
  • WTFC $120.61
  • Resistance Level
  • ROIV $11.77
  • WTFC $123.40
  • Average True Range (ATR)
  • ROIV 0.34
  • WTFC 2.43
  • MACD
  • ROIV -0.08
  • WTFC 1.27
  • Stochastic Oscillator
  • ROIV 15.13
  • WTFC 91.64

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

Share on Social Networks: